Optimising P2Y12 inhibition in real world clinical practice: clinical outcomes of prasugrel and ticagrelor.
Topic:
Thrombosis and platelets
Speaker:
Professor J. Jukema (Leiden, NL)
Sponsored by Daiichi Sankyo Europe GmbH
Event:
ESC Congress 2016
Congress Presentation
About the speaker
Professor J Wouter Jukema
Leiden University Medical Center, Leiden (Netherlands (The))
20
presentations
0
follower
3 more presentations in this session
Welcome & introduction: Potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Speaker: Professor K. Huber (Vienna, AT)
Discussion – Summary and closing remarks: potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Speaker: Professor K. Huber (Vienna, AT)
Access the full session
Potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Speakers:
Professor J. Jukema, Professor K. Huber, Professor A. Schaefer, Professor K. Huber
About the event
ESC 365 is supported by
